Close

Seattle Genetics (SGEN), Takeda Announce Completion of ADCETRIS Phase 3 Enrollment in rontline Mature T-cell Lymphoma

Go back to Seattle Genetics (SGEN), Takeda Announce Completion of ADCETRIS Phase 3 Enrollment in rontline Mature T-cell Lymphoma